Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/02/1995 | WO1995029186A1 Compositions and methods for cell transformation |
11/02/1995 | WO1995028959A1 MICE MUTANT FOR Fc RECEPTORS AND METHOD OF TREATING AUTOIMMUNE DISEASE |
11/02/1995 | WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft |
11/02/1995 | WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
11/02/1995 | WO1995028948A1 Compositions comprising dna damaging agents and p53 |
11/02/1995 | WO1995028942A1 Antisense oligomers for inhibiting human papillomaviruses |
11/02/1995 | WO1995028941A1 Composition and method for treatment of cmv infection |
11/02/1995 | WO1995027718A3 Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography |
11/02/1995 | WO1995027060A3 Biologically active eph family ligands |
11/02/1995 | WO1995026410A3 Biological insect control agent |
11/02/1995 | EP0679718A2 Process for producing alpha-interferon |
11/02/1995 | EP0679717A2 Soluble interferon -receptor, its preparation and use |
11/02/1995 | EP0679716A1 Gene signature |
11/02/1995 | EP0679196A1 Dna sequencing by mass spectrometry |
11/02/1995 | EP0679194A1 Method to predict active growth of bacteria adhered to a surface |
11/02/1995 | EP0679192A1 Improved recombinant production of proteins having factor viii:c activity |
11/02/1995 | EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene |
11/02/1995 | EP0679190A1 Method for generating single-stranded dna molecules |
11/02/1995 | EP0679189A1 Cloning of enterokinase and method of use |
11/02/1995 | EP0679188A1 Modified cutinases, dna, vector and host |
11/02/1995 | EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv. |
11/02/1995 | EP0679186A1 Monokine mig induced by ifn-gamma |
11/02/1995 | EP0679185A1 Ras associated gap proteins |
11/02/1995 | EP0679184A1 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same |
11/02/1995 | EP0679182A1 Delivery of gene products via mesangial cells |
11/02/1995 | EP0679163A1 Growth differentiation factor-3 |
11/02/1995 | EP0679094A1 Compounds for targeting |
11/02/1995 | EP0679089A1 Methods for promoting cartilage matrix formation |
11/02/1995 | EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
11/02/1995 | EP0517833B1 Regeneration and genetic transformation of sugar beet |
11/02/1995 | EP0404967B1 Recombinant c-terminal alpha-amidating enzyme of human thyroid origin |
11/02/1995 | DE4415001A1 Treatment of eukaryotic cells with cpds. that bind lipo-polysaccharide |
11/02/1995 | CA2722364A1 Melanoma antigens |
11/02/1995 | CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft |
11/02/1995 | CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
11/02/1995 | CA2188418A1 Genetic sequences conferring disease resistance in plants and uses therefor |
11/02/1995 | CA2188397A1 Human sperm diagnostic |
11/02/1995 | CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
11/02/1995 | CA2188320A1 Compositions and methods for cell transformation |
11/02/1995 | CA2188258A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines |
11/02/1995 | CA2188257A1 Dna encoding cephamycin biosynthesis late enzymes |
11/02/1995 | CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/02/1995 | CA2187920A1 Spider neurotoxins and method of producing the same |
11/02/1995 | CA2185673A1 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same |
11/02/1995 | CA2185560A1 Detection of fungal pathogens using the polymerase chain reaction |
11/02/1995 | CA2185550A1 An in vivo gene expression system |
10/31/1995 | US5463175 Glyphosate tolerant plants |
10/31/1995 | US5463174 Transformation and foreign gene expression in Brassica species |
10/31/1995 | US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin |
10/31/1995 | US5463026 Anti-human prohibitin antibodies |
10/31/1995 | US5463025 Protein having human plasmin inhibiting activity |
10/31/1995 | US5463024 Antigen-presenting assembled particle comprising protein molecules of self-assembling, particle-forming polypeptide encoded by gag gene of retrovirus fused to polypeptide defining viral, bacterial or protozoal antigenic epitope |
10/31/1995 | US5462925 Transforming growth factor β2,3 |
10/31/1995 | US5462873 DNA for use in a simple method for detecting inhibitors of retrotransposition |
10/31/1995 | US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes |
10/31/1995 | US5462864 Manufacturing method of high purity maltose and its reduced product |
10/31/1995 | US5462862 Antibiotics from microorganisms |
10/31/1995 | US5462856 Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
10/31/1995 | US5462855 Method for the detection and quantitative determination of nitrosomonas strains in wastewaters or soils |
10/31/1995 | US5462854 Amenable to enzymatic elongation from either, or most preferably both termini under appropriate conditions and in presence of polymerase enzyme |
10/31/1995 | US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core |
10/31/1995 | CA2002516C Process for the expression of a recombinant gene |
10/30/1995 | CA2122874A1 Neural receptor tyrosine kinase |
10/28/1995 | CA2147933A1 Transgenic animals as a model for metabolic bone diseases |
10/26/1995 | WO1995028500A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
10/26/1995 | WO1995028496A1 Method for preparing template dna from cell cultures |
10/26/1995 | WO1995028494A1 Gene delivery fusion proteins |
10/26/1995 | WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system |
10/26/1995 | WO1995028492A1 Dna regulatory elements responsive to cytokines |
10/26/1995 | WO1995028491A1 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
10/26/1995 | WO1995028490A1 Expression vector with non-viral promoter |
10/26/1995 | WO1995028489A1 Dihydropyrimidine dehydrogenase compositions and methods of use |
10/26/1995 | WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220 |
10/26/1995 | WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
10/26/1995 | WO1995028486A2 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles |
10/26/1995 | WO1995028485A1 Erbb2 promoter binding protein in neoplastic disease |
10/26/1995 | WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
10/26/1995 | WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto |
10/26/1995 | WO1995028482A2 Dna spacer regulatory elements responsive to cytokines and methods for their use |
10/26/1995 | WO1995028481A1 Conserved t-cell receptor sequences |
10/26/1995 | WO1995028478A1 Rps2 gene and uses thereof |
10/26/1995 | WO1995028476A1 Recombinant zymomonas for pentose fermentation |
10/26/1995 | WO1995028474A1 Dna encoding bradykinin b1 receptor |
10/26/1995 | WO1995028423A1 Rps gene family, primers, probes, and detection methods |
10/26/1995 | WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
10/26/1995 | WO1995028412A1 α(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE |
10/26/1995 | WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
10/26/1995 | WO1995028409A1 Process, apparatus and reagents for isolating cellular components |
10/26/1995 | WO1995028172A1 Human bone stimulating factor |
10/26/1995 | WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
10/26/1995 | WO1995027047A3 Highly-purified recombinant reverse transcriptase |
10/26/1995 | WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes |
10/26/1995 | DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis |
10/26/1995 | CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
10/26/1995 | CA2188317A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
10/26/1995 | CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
10/26/1995 | CA2188182A1 Conserved t-cell receptor sequences |
10/26/1995 | CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
10/26/1995 | CA2188172A1 Human bone stimulating factor |
10/26/1995 | CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |